On March 14, 2019, Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF) (Frankfurt: A2JMZC) and Dixie Brands Inc. (CSE: DIXI.U) (Frankfurt: 0QV) (OTC: DXBRF) signed a definitive agreement relating to their previously announced joint venture. With the execution of the agreement, a new company called Dixie Khiron JV Corp. ("Dixie-Khiron") has been established, 50% owned by each of Dixie and Khiron. Dixie-Khiron will take advantage of the complementary strengths of both companies to manufacture and distribute cannabis-infused products to the Latin American market.
Khiron is a vertically integrated cannabis leader with core operations in Latin America. It operates in the Colombian market and has incorporated entities and obtained certain licenses with an objective to enter the Peru, Chile and Mexico markets. Khiron has also announced plans to enter Brazil and Uruguay through its proposed acquisition of NettaGrowth International Inc.
Dixie is one of the cannabis industry's leading consumer packaged goods ("CPG") companies, currently operating in five US states. The company is expecting to double its manufacturing and distribution capabilities in 2019 in the US as well as expand internationally, including Canada and Latin America.
Gowling WLG advised Khiron with respect to the negotiation of this joint venture with a team led by Peter Simeon and that included Peter Doelman and Bryinne McCoy (corporate), Roch Ripley and Stephen Cross (IP), assisted by student-at-law Aliana Dhanani.
Read the original article on GowlingWLG.com.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
